Twist Bioscience price target raised to $65 from $55 at Barclays

Barclays raised the firm’s price target on Twist Bioscience (TWST) to $65 from $55 and keeps an Overweight rating on the shares. The company reported solid results “across the board,” the analyst tells investors in a research note. The firm says that while Twist’s AI business “catches all of the headlines,” the core probes and sequencing business continue to show good demand.